Viewing Study NCT03355066


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-02-02 @ 9:14 PM
Study NCT ID: NCT03355066
Status: TERMINATED
Last Update Posted: 2024-08-09
First Post: 2017-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors
Sponsor: Biosplice Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SM08502 View
None pan Clk/Dyrk inhibitor View
None HRR View
None HRD View
None LOH High View
None AR-V7 View